[HTML][HTML] Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants …
L Li, X Chen, Z Wang, Y Li, C Wang, L Jiang… - PLoS …, 2023 - journals.plos.org
The rapid emergence of SARS-CoV-2 variants of concern (VOCs) calls for efforts to study
broadly neutralizing antibodies elicited by infection or vaccination so as to inform the …
broadly neutralizing antibodies elicited by infection or vaccination so as to inform the …
The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter
R Suzuki, A Kamiyama, H Ito, K Kawashiro… - Journal of Virological …, 2024 - Elsevier
Many methods have been developed to measure the neutralizing capacity of antibodies to
SARS-CoV-2. However, these methods are low throughput and can be difficult to quickly …
SARS-CoV-2. However, these methods are low throughput and can be difficult to quickly …
[HTML][HTML] Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody
YH Chang, MF Hsu, WN Chen, MH Wu, WL Kong… - JCI insight, 2024 - ncbi.nlm.nih.gov
Since its emergence, SARS-CoV-2 has been continuously evolving, hampering the
effectiveness of current vaccines against COVID-19. mAbs can be used to treat patients at …
effectiveness of current vaccines against COVID-19. mAbs can be used to treat patients at …
[HTML][HTML] Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
Y Chen, C Hu, Z Wang, J Su, S Wang, B Li, X Liu… - Pathogens, 2023 - mdpi.com
Vaccination has proven to be highly effective against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), but the long-term immunogenicity and the functional …
coronavirus 2 (SARS-CoV-2), but the long-term immunogenicity and the functional …
[HTML][HTML] Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 Convalescent
Y Hu, C Hu, S Wang, L Ren, Y Hao, Z Wang, Y Liu… - Pathogens, 2024 - mdpi.com
Since November 2021, Omicron has emerged as the dominant severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) variant, and its sublineages continue to appear one …
syndrome coronavirus 2 (SARS-CoV-2) variant, and its sublineages continue to appear one …